Riskpilot← Back to searchSign inGet full accessSciMont AB
ABActiveOrg 5566673744Dammgatan 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 20040 employees
Revenue 2024
SEK 928K
EBITDA margin
12.7%
-31% vs 2023
Equity ratio
-20.9%
Financial strength
Net profit 2024
SEK 119K
-6% vs 2023
| Revenue | SEK 928K | — |
| EBITDA | SEK 118K | -31% |
| Net profit | SEK 119K | -6% |
| Total assets | SEK 2,4M | +11% |
| Equity | SEK -493K | +19% |
| Employees | 0 | — |
Legal name
SciMont AB
Org number
5566673744
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 september 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, utveckla, marknadsföra, licensiera och sälja produkter inom området nanoteknologi och optik, samt tillhandahålla konsulttjänster inom detta område samt inneha och förvalta aktier och andelar i andra bolag, utlicensiering av immateriella rättigheter, samt därmed förenlig verksamhet.
Address
Dammgatan 4
Phone
+4646291035
Email
montelius@mac.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | 0 | 928 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | −33 | −27 | 0 | 170 | 118 |
| Depreciation & amort. | −0 | −0 | — | −0 | — |
| EBIT | −33 | −27 | 0 | 170 | 118 |
| Net financials | −25 | −31 | — | −44 | 1 |
| Profit before tax | −58 | −58 | 0 | 126 | 119 |
| Tax | −0 | −0 | — | −0 | — |
| Net profit | −58 | −58 | — | 126 | 119 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 194 | 1 476 | — | 2 133 | 2 360 |
| Equity | −589 | −647 | — | −611 | −493 |
| Long-term debt | 1 531 | 1 852 | — | 2 686 | 2 548 |
| Short-term debt | 251 | 271 | — | 58 | 304 |
| Total debt | 1 782 | 2 123 | — | 2 744 | 2 852 |
EBITDA margin
12.7%
This company
15.8%
Market median
-20% vs market
20202024
Equity ratio
-20.9%
This company
38.2%
Market median
-155% vs market
20202024
Return on equity
11863700.0%
This company
18.4%
Market median
+64476530% vs market
20202024
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20202024
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20202024
Debt / equity
5.79×
This company
0.62×
Market median
-834% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SciMont AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gösta Montelius | Chief Executive Officer | 0 companies |
| Anna Caroline Elisabeth Montelius | Deputy Board Member | 0 companies |
| Anna Cecilia Victoria Montelius | Deputy Board Member | 0 companies |